Main Article Content

Abstract

Effective drug delivery requires overcoming multiple biological barriers, including enzymatic degradation, immune clearance, and poor tissue penetration. This review systematically presents the design strategies for nanocarriers — including surface modification, stimuli-responsive release, and active targeting ligands — to enhance therapeutic index and specificity. We discuss recent advances in polymeric nanoparticles, liposomes, dendrimers, and exosome-based carriers, emphasizing their applications in cancer, infectious diseases, and neurological disorders

Keywords

Biological Barriers Cancer Therapy Controlled Release Dendrimers Exosomes Liposomes Nanocarriers Neurodegeneration Polymeric Nanoparticles Targeted Drug Delivery

Article Details

How to Cite
1.
Al Temimi T, Reda HM, Elfeshawy R, Al Sa'ady AT, Hindi SKK. Nanocarriers in Targeted Drug Delivery: Design Strategies to Overcome Biological Barriers. TPB [Internet]. 2025 Jun. 30 [cited 2025 Sep. 27];3(1):64-9. Available from: https://tpb.nabea.pub/tpb/article/view/28

How to Cite

1.
Al Temimi T, Reda HM, Elfeshawy R, Al Sa'ady AT, Hindi SKK. Nanocarriers in Targeted Drug Delivery: Design Strategies to Overcome Biological Barriers. TPB [Internet]. 2025 Jun. 30 [cited 2025 Sep. 27];3(1):64-9. Available from: https://tpb.nabea.pub/tpb/article/view/28

Similar Articles

You may also start an advanced similarity search for this article.